HomeOMCL • NASDAQ
Omnicell Inc
$42.55
Sep 26, 7:00:00 AM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$42.55
Day range
$42.26 - $43.48
Year range
$25.13 - $47.28
Market cap
1.96B USD
Avg Volume
527.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD)Jun 2024Y/Y change
Revenue
276.79M-7.42%
Operating expense
111.13M-11.95%
Net income
3.74M8.23%
Net profit margin
1.3517.39%
Earnings per share
0.51-10.53%
EBITDA
17.66M-23.71%
Effective tax rate
54.43%—
Total assets
Total liabilities
(USD)Jun 2024Y/Y change
Cash and short-term investments
556.78M39.38%
Total assets
2.29B4.46%
Total liabilities
1.09B5.68%
Total equity
1.20B—
Shares outstanding
45.99M—
Price to book
1.63—
Return on assets
0.35%—
Return on capital
0.44%—
Net change in cash
(USD)Jun 2024Y/Y change
Net income
3.74M8.23%
Cash from operations
58.70M-19.48%
Cash from investing
-13.55M8.56%
Cash from financing
-16.63M-561.50%
Net change in cash
28.28M-54.14%
Free cash flow
51.07M-11.53%
About
Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth. Wikipedia
Founded
Sep 1992
Employees
3,630
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu